ArticleFrontiers in pharmacology2022

Dual-targeting cyclic peptides of receptor-binding domain (RBD) and main protease (Mpro) as potential drug leads for the treatment of SARS-CoV-2 infection.

Zhen Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.